• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑与体的交汇:血脑屏障作为内分泌界面。

Brain meets body: the blood-brain barrier as an endocrine interface.

机构信息

Veterans Affairs Puget Sound Health Care System and Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

出版信息

Endocrinology. 2012 Sep;153(9):4111-9. doi: 10.1210/en.2012-1435. Epub 2012 Jul 9.

DOI:10.1210/en.2012-1435
PMID:22778219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3423627/
Abstract

The blood-brain barrier (BBB) separates the central nervous system (CNS) from the peripheral tissues. However, this does not prevent hormones from entering the brain, but shifts the main control of entry to the BBB. In general, steroid hormones cross the BBB by transmembrane diffusion, a nonsaturable process resulting in brain levels that reflect blood levels, whereas thyroid hormones and many peptides and regulatory proteins cross using transporters, a saturable process resulting in brain levels that reflect blood levels and transporter characteristics. Protein binding, brain-to-blood transport, and pharmacokinetics modulate BBB penetration. Some hormones have the opposite effect within the CNS than they do in the periphery, suggesting that these hormones cross the BBB to act as their own counterregulators. The cells making up the BBB are also endocrine like, both responding to circulating substances and secreting substances into the circulation and CNS. By dividing a hormone's receptors into central and peripheral pools, the former of which may not be part of the hormone's negative feed back loop, the BBB fosters the development of variable hormone resistance syndromes, as exemplified by evidence that altered insulin action in the CNS can contribute to Alzheimer's disease. In summary, the BBB acts as a regulatory interface in an endocrine-like, humoral-based communication between the CNS and peripheral tissues.

摘要

血脑屏障(BBB)将中枢神经系统(CNS)与外周组织隔开。然而,这并不能阻止激素进入大脑,而是将进入大脑的主要控制转移到 BBB。一般来说,甾体激素通过跨膜扩散穿过 BBB,这是一种非饱和过程,导致大脑中的水平反映血液中的水平,而甲状腺激素和许多肽和调节蛋白则通过转运蛋白穿过,这是一个饱和过程,导致大脑中的水平反映血液中的水平和转运蛋白的特征。蛋白结合、脑向血液的转运和药代动力学调节 BBB 的穿透性。一些激素在中枢神经系统中的作用与在外周组织中的作用相反,这表明这些激素穿过 BBB 作为自身的反向调节剂。构成 BBB 的细胞也具有内分泌样特征,既能对外周循环中的物质做出反应,又能将物质分泌到循环和中枢神经系统中。通过将激素的受体分为中枢和外周池,前者可能不是激素负反馈循环的一部分,BBB 促进了可变的激素抵抗综合征的发展,例如有证据表明,中枢神经系统中胰岛素作用的改变可能导致阿尔茨海默病。总之,BBB 作为中枢神经系统和外周组织之间基于体液的内分泌样通讯的调节界面。

相似文献

1
Brain meets body: the blood-brain barrier as an endocrine interface.脑与体的交汇:血脑屏障作为内分泌界面。
Endocrinology. 2012 Sep;153(9):4111-9. doi: 10.1210/en.2012-1435. Epub 2012 Jul 9.
2
The blood-brain barrier as an endocrine tissue.血脑屏障作为一种内分泌组织。
Nat Rev Endocrinol. 2019 Aug;15(8):444-455. doi: 10.1038/s41574-019-0213-7.
3
The source of cerebral insulin.脑胰岛素的来源。
Eur J Pharmacol. 2004 Apr 19;490(1-3):5-12. doi: 10.1016/j.ejphar.2004.02.040.
4
Blood-brain barrier as a regulatory interface.血脑屏障作为一个调节界面。
Forum Nutr. 2010;63:102-110. doi: 10.1159/000264398. Epub 2009 Nov 27.
5
The blood-brain barrier: connecting the gut and the brain.血脑屏障:连接肠道与大脑。
Regul Pept. 2008 Aug 7;149(1-3):11-4. doi: 10.1016/j.regpep.2007.08.027. Epub 2008 Apr 7.
6
Delivery of peptides to the brain: emphasis on therapeutic development.肽向大脑的递送:重点在于治疗性开发。
Biopolymers. 2008;90(5):589-94. doi: 10.1002/bip.20980.
7
Transport of nutrients and hormones through the blood-brain barrier.营养物质和激素通过血脑屏障的运输。
Fed Proc. 1984 Feb;43(2):201-4.
8
The blood-brain barrier as a regulatory interface in the gut-brain axes.血脑屏障作为肠-脑轴中的一个调节界面。
Physiol Behav. 2006 Nov 30;89(4):472-6. doi: 10.1016/j.physbeh.2006.07.004. Epub 2006 Aug 10.
9
Insulin blood-brain barrier transport and interactions are greater following exercise in mice.运动后,胰岛素在小鼠的血脑屏障中的转运和相互作用增强。
J Appl Physiol (1985). 2022 Mar 1;132(3):824-834. doi: 10.1152/japplphysiol.00866.2021. Epub 2022 Feb 17.
10
Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.血脑屏障和脑实质中的转运体和酶对中枢神经系统药物摄取的影响。
Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):961-972. doi: 10.1080/17425255.2018.1513493. Epub 2018 Sep 5.

引用本文的文献

1
Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context.关键血脑屏障调节因子表达中的性别和年龄差异:生理背景
Biol Sex Differ. 2025 Sep 2;16(1):67. doi: 10.1186/s13293-025-00751-2.
2
Lifetime Variations in Prolactin Expression in the Hippocampus and Dentate Gyrus of the Rat.大鼠海马体和齿状回中催乳素表达的终生变化
Int J Mol Sci. 2025 Jul 28;26(15):7299. doi: 10.3390/ijms26157299.
3
Exploring neuroendocrine influences on the sensorimotor-association axis in a female and a male individual.探究神经内分泌对一名女性和一名男性个体感觉运动-联合轴的影响。
Imaging Neurosci (Camb). 2025 Feb 18;3. doi: 10.1162/imag_a_00474. eCollection 2025.
4
The role of androgens in migraine pathophysiology.雄激素在偏头痛病理生理学中的作用。
Neurobiol Pain. 2024 Oct 6;16:100171. doi: 10.1016/j.ynpai.2024.100171. eCollection 2024 Jul-Dec.
5
Blood-brain barrier disruption: a culprit of cognitive decline?血脑屏障破坏:认知衰退的罪魁祸首?
Fluids Barriers CNS. 2024 Aug 7;21(1):63. doi: 10.1186/s12987-024-00563-3.
6
The role of estrogen in Alzheimer's disease pathogenesis and therapeutic potential in women.雌激素在女性阿尔茨海默病发病机制中的作用及治疗潜力。
Mol Cell Biochem. 2025 Apr;480(4):1983-1998. doi: 10.1007/s11010-024-05071-4. Epub 2024 Aug 1.
7
Obesity-induced inflammation: connecting the periphery to the brain.肥胖诱导的炎症:连接外周与大脑。
Nat Metab. 2024 Jul;6(7):1237-1252. doi: 10.1038/s42255-024-01079-8. Epub 2024 Jul 12.
8
Potential Differences in Psychedelic Actions Based on Biological Sex.基于生物学性别差异的迷幻药物作用的潜在差异。
Endocrinology. 2024 Jul 1;165(8). doi: 10.1210/endocr/bqae083.
9
Chronic Social Defeat Stress Increases Brain Permeability to Ghrelin in Male Mice.慢性社交挫败应激增加雄性小鼠脑对 ghrelin 的通透性。
eNeuro. 2024 Jul 16;11(7). doi: 10.1523/ENEURO.0093-24.2024. Print 2024 Jul.
10
Circadian Rhythms of the Blood-Brain Barrier and Drug Delivery.血脑屏障的昼夜节律和药物递送。
Circ Res. 2024 Mar 15;134(6):727-747. doi: 10.1161/CIRCRESAHA.123.323521. Epub 2024 Mar 14.

本文引用的文献

1
Activation of promoter activity of the catalytic subunit of γ-glutamylcysteine ligase (GCL) in brain endothelial cells by insulin requires antioxidant response element 4 and altered glycemic status: implication for GCL expression and GSH synthesis.胰岛素激活脑内皮细胞γ-谷氨酰半胱氨酸连接酶(GCL)催化亚基启动子活性需要抗氧化反应元件 4 和改变的血糖状态:对 GCL 表达和 GSH 合成的影响。
Free Radic Biol Med. 2011 Nov 1;51(9):1749-57. doi: 10.1016/j.freeradbiomed.2011.08.004. Epub 2011 Aug 12.
2
Impaired baroreflex gain during pregnancy in conscious rats: role of brain insulin.在清醒大鼠怀孕期间,压力反射增益受损:脑胰岛素的作用。
Hypertension. 2011 Feb;57(2):283-8. doi: 10.1161/HYPERTENSIONAHA.110.162354. Epub 2010 Dec 13.
3
Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions.糖皮质激素经中枢神经系统(CNS)给药,由血脑屏障和非屏障区域的可饱和转运体进行精细调控。
Endocrinology. 2010 Nov;151(11):5294-305. doi: 10.1210/en.2010-0554. Epub 2010 Sep 29.
4
Insulin detemir is not transported across the blood-brain barrier.德谷胰岛素不能透过血脑屏障转运。
Peptides. 2010 Dec;31(12):2284-8. doi: 10.1016/j.peptides.2010.09.011. Epub 2010 Sep 22.
5
Cerebral microvascular IL15 is a novel mediator of TNF action.脑微血管白细胞介素-15是肿瘤坏死因子作用的一种新型介质。
J Neurochem. 2009 Nov;111(3):819-27. doi: 10.1111/j.1471-4159.2009.06371.x. Epub 2009 Aug 31.
6
Insulin detemir causes increased symptom awareness during hypoglycaemia compared to human insulin.地特胰岛素相较于人胰岛素会引起低血糖时症状感知增加。
Diabetes Obes Metab. 2009 Nov;11(11):1017-26. doi: 10.1111/j.1463-1326.2009.01085.x. Epub 2009 Jul 23.
7
Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells.血管紧张素II通过激活脑内皮细胞中的AT(1)受体来调节血脑屏障的通透性。
J Cereb Blood Flow Metab. 2009 Mar;29(3):640-7. doi: 10.1038/jcbfm.2008.158. Epub 2009 Jan 7.
8
Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.在超重2型糖尿病患者强化胰岛素治疗中,与中性鱼精蛋白锌胰岛素相比,每日一次地特胰岛素体重增加更少且低血糖发生率更低:PREDICTIVE BMI临床试验
Diabet Med. 2008 Aug;25(8):916-23. doi: 10.1111/j.1464-5491.2008.02483.x.
9
Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.与中性鱼精蛋白锌胰岛素相比,地特胰岛素导致体重增加减少并非由低血糖减少所致。
Diabetes Technol Ther. 2008 Aug;10(4):273-7. doi: 10.1089/dia.2008.0282.
10
Cytokine transport across the injured blood-spinal cord barrier.细胞因子穿过受损的血脊髓屏障的转运。
Curr Pharm Des. 2008;14(16):1620-4. doi: 10.2174/138161208784705450.